bioRxivImmunologyPreprint
DEAD-box RNA helicase 18 disrupts IRF3-binding to the interferon-β promoter
S. Xiao, X. Xiao, M. Wang, W. Zhao, P. Fang, Y. Zhou, D. Wang, L. Fang
Abstract
The production of type I interferons (IFN-/{beta}) requires strict control to avoid excessive activation during viral infections. The binding of interferon regulatory factor 3 (IRF3) to the IFN-{beta} promoter region in the nucleus is essential for IFN-{beta} transcription; however, whether nuclear factors have important negative-regulatory roles in this process is largely unknown. By screening for IRF3-interacting partners in the nucleus, we identified DEAD-box RNA helicase 18 (DDX18) as an important negative regulator of intranuclear IRF3. Overexpression of DDX18 suppressed virus- and IRF3-induced IFN-{beta} production, whereas knockdown of DDX18 expression or knockout of the DDX18 gene had opposite effects. Mechanistically, DDX18 interacts with IRF3 and decreases the binding of IRF3 to the IFN-{beta} promoter after viral infection. DDX18 knockdown mice (Ddx18+/-) further demonstrated that DDX18 suppressed antiviral innate immunity in vivo. Thus, despite many members of the DDX family act as important positive regulators in the cytoplasm, DDX18 plays a unique "braking" role in balancing virus-induced type I IFN production.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NAT10 Suppresses RNA Sensing Induced IFN-β Transactivation to Promote Viral Infection via Interfering with IRF3 Activities
Youngmin Park, Jinshan He, … Jian Kang Zhu·bioRxiv·Sep 1, 2025
- Identification of Interleukin1β as an Amplifier of Interferon alpha-induced Antiviral Responses
Katharina Robichon, Tim Maiwald, … Ursula Klingmüller·PLoS PathogensPeer-reviewed·Oct 1, 2020
- Modeling the Co-Activation of Inflammatory Genes1Mediated by NFκB and IRF-3 During Viral Infections
Syona Tiwari, Soumen Basak, R. Pandey·bioRxiv·May 13, 2025
- ILF3 contributes to the establishment of the antiviral type I interferon program
Samir F. Watson, Nicolás Bellora, Sara Macías·Nucleic Acids ResearchPeer-reviewed·Nov 4, 2019
- DDX50 is a viral restriction factor thay enhances TRIF-dependent IRF3 activation
M. A. Pallett, Y. Lu, G. L. Smith·bioRxiv·Aug 6, 2020
- IRF1 Tunes Basal Immunity and Antiviral Readiness in a Context-Dependent Manner
Eyal Zoler, Irina Miodownik, … Gideon Schreiber·Journal of Biological ChemistryPeer-reviewed·Dec 30, 2025